Impact of BMI on HbA(1c) reduction in response to IDegLira in subjects with type 2 diabetes uncontrolled on SU, GLP-IRA or IGlar U100: analyses from completed phase 3b trials E. Jodar, S. B. Harris,E. Jaeckel,I. Lingvay,K. Chandarana,T. Abrahamsen,C. H. SorliDIABETOLOGIA（2016）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
